Skip to main content

Find Clinical Trials

Home
Conditions
Uterine Cervical Diseases

Clinical trial condition

Uterine Cervical Diseases

Explore clinical trials studying Uterine Cervical Diseases. Study availability and eligibility vary by location and protocol.

1,755 public trials 370 recruiting studies

Refine in advanced search Browse all conditions

Uterine Cervical Diseases trial results

Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations: GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site San Francisco, California, United States

GSK Investigational Site Vista, California, United States

View all 40 locations

View Trial Details

Completed

HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs

NCT04133610

Conditions: Cervical Cancer, Cervical Dysplasia, Communicable Diseases, +26 more
Locations: GYN-PREN, Ltd. Frýdek-Místek, Czechia

GYNPRENATAL, Ltd. Havířov, Czechia

MEDIOL, Ltd. Olomouc, Czechia

View Trial Details

Completed

Suitability of DCE-MRI for Detection of Vascular Changes After VBT

NCT01991808

Conditions: Carcinoma, Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus, Female Urogenital Diseases, +14 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)

NCT03158220

Conditions: Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +36 more
Locations: Universitatsklinik fuer Frauenheilkunde und Geburtshilfe ( Site 0002) Graz, Austria

Klin. Abtlg. fuer Gynaekologie und Geburtshilfe ( Site 0001) Vienna, Austria

Universitair Ziekenhuis Antwerpen ( Site 0007) Edegem, Belgium

Universitair Ziekenhuis Gent ( Site 0006) Ghent, Belgium

View all 24 locations

View Trial Details

Completed

Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer

NCT00205010

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: University of Wisconsin Madison, Wisconsin, United States

View Trial Details

Completed

Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

NCT02096783

Conditions: Adnexal Diseases, Anxiety Disorder, Anxiety Disorders, +44 more
Locations: University of Wisconsin, Madison Madison, Wisconsin, United States

View Trial Details

Completed

Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents

NCT00534638

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Kotka, Finland

GSK Investigational Site Kuopio, Finland

GSK Investigational Site Lahti, Finland

GSK Investigational Site Rauma, Finland

View Trial Details

Completed

Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women

NCT01298596

Conditions: Cervical Intraepithelial Neoplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations: Coptic Hospital Nairobi, Kenya

View Trial Details

Completed

HPV Vaccination Among Daughters of Latina Immigrants

NCT04154319

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Not specified

View Trial Details

Completed

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

NCT01190176

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Iowa City, Iowa, United States

GSK Investigational Site Wichita, Kansas, United States

GSK Investigational Site Wenatchee, Washington, United States

GSK Investigational Site Edmonton, Alberta, Canada

View all 20 locations

View Trial Details